Friday, January 28, 2022 12:44:07 PM
I completely agree with your post and the last one. It's horrible what the MM's get away with. And they never seem to get in trouble for it. I can not wrap my head around how ANYONE can do naked shorting. I understand it but how is it legal?! To just sell shares that don't even exist just to keep the prices down. Anyway enough of my rant. Best of luck to all of us retail, especially us longs. Take care and have a nice weekend
Recent BNGO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:16:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:29:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:09:36 PM
- Bionano Reports First Quarter 2026 Results and Provides a Business Update • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:03:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2026 08:02:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:30:53 PM
- Bionano Announces Leadership Transition • GlobeNewswire Inc. • 05/06/2026 08:30:00 PM
- Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:51 PM
- Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/25/2026 08:28:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:08:58 PM
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 • GlobeNewswire Inc. • 03/23/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:04:52 PM
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:31:45 PM
